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Mitochondrial Genetic Background Modulates Bioenergetics and Susceptibility to
Acute Cardiac Volume Overload
Abstract
Dysfunctional bioenergetics has emerged as a key feature in many chronic pathologies such as diabetes
and cardiovascular disease. This has led to the mitochondrial paradigm in which it has been proposed
that mtDNA sequence variation contributes to disease susceptibility. In the present study we show a
novel animal model of mtDNA polymorphisms, the MNX (mitochondrial–nuclear exchange) mouse, in
which the mtDNA from the C3H/HeN mouse has been inserted on to the C57/BL6 nuclear background
and vice versa to test this concept. Our data show a major contribution of the C57/BL6 mtDNA to the
susceptibility to the pathological stress of cardiac volume overload which is independent of the nuclear
background. Mitochondria harbouring the C57/BL6J mtDNA generate more ROS (reactive oxygen
species) and have a higher mitochondrial membrane potential relative to those with C3H/HeN mtDNA,
independent of nuclear background. We propose this is the primary mechanism associated with
increased bioenergetic dysfunction in response to volume overload. In summary, these studies support
the ‘mitochondrial paradigm’ for the development of disease susceptibility, and show that the mtDNA
modulates cellular bioenergetics, mitochondrial ROS generation and susceptibility to cardiac stress.
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Synopsis
Dysfunctional bioenergetics has emerged as a key feature in many chronic pathologies such as
diabetes and cardiovascular disease. This has led to the mitochondrial paradigm in which it has
been proposed that mitochondrial DNA (mtDNA) sequence variation contributes to disease
susceptibility. In this study we present a novel animal model of mtDNA polymorphisms, the
mitochondrial nuclear exchange mouse (MNX), in which the mtDNA from C3H/HeN mouse has
been inserted onto the C57/BL6 nuclear background and vice versa to test this concept. Our data
show a major contribution of the C57/BL6 mtDNA to the susceptibility to the pathological stress
of cardiac volume overload which is independent of the nuclear background. Mitochondria
harboring the C57/BL6J mtDNA generate more reactive oxygen species (ROS) and have a higher
mitochondrial membrane potential relative to those having the C3H/HeN mtDNA, independent of
nuclear background. We propose this is the primary mechanism associated with increased
bioenergetic dysfunction in response to volume overload. In summary, these studies support the
“mitochondrial paradigm” for the development of disease susceptibility, and show that the
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mtDNA modulates, cellular bioenergetics, mitochondrial reactive oxygen species generation and
susceptibility to cardiac stress.
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Introduction
While significant progress has been made in understanding the pathobiology underlying
heart disease development and progression, it is still not clear why some individuals with
identical risk factors develop disease while others do not. It is widely thought that disease
development is influenced by a combination of genetic, environmental, and behavioral
factors that influence an individual’s biological response to disease risk factors. However,
studies have not yet provided a clear genetic or mechanistic basis for “common” disease
susceptibility. In this regard, the potential contribution of mitochondrial genetics and
function is a consideration that has largely been lacking from prior susceptibility analyses.
This “mitochondrial paradigm” for disease has been difficult to critically assess due the lack
of animal models in which it can be tested. In this study we describe a novel approach to
developing such models and illustrate its application in a model of bioenergetic dysfunction
in the heart.
Mitochondria are ancient bacterial symbionts with their own DNA, RNA, and protein
synthesis systems [1]. Each cell contains hundreds to thousands of mitochondria and every
mitochondrion contains 5 – 10 copies of maternally inherited mtDNA. The mammalian
mtDNA encodes two rRNAs (12S and 16S) and 22 tRNAs that are necessary for the proper
translation of 13 mtDNA genes that encode polypeptides essential for electron transport and
oxidative phosphorylation (OXPHOS). While the nucleus encodes all of the remaining
mitochondrial proteins for the organelle, the mtDNA retains key structural subunits required
for the catalytic activity of four of the five OXPHOS enzyme complexes (I, III, IV and V). It
is clear that mutations in these mtDNA subunits alter the basic features of mitochondrial
metabolism as has been shown in a broad range of mitochondrial diseases in which
substantial loss of respiratory function occurs [2]. Recently, the contribution of functional
but distinct mitochondrial DNA polymorphisms present in different human populations, to
the susceptibility disease has been proposed [2]. While mtDNA sequence variation has been
investigated in certain animal models of disease [3] few experimental models are available
to test this hypothesis which is supported by human epidemiological data.
The mitochondrial paradigm has been proposed as a mechanism of how prehistoric humans
were able to successfully establish populations out of Africa through exploiting mtDNA
mutations which subtly alter mitochondrial bioenergetics. The key concept is that mtDNA
haplotypes that promote heat generation conveyed greater reproductive and survival
potential in our prehistoric ancestors even at some cost to energetic efficiency [4]. Today, in
the presence of excessive dietary intake and sedentary lifestyle it is hypothesized that these
mtDNA mutations will be linked to differences in bioenergetics and oxidant production, and
thus, influence susceptibility to age-related diseases associated with increased oxidative
stress or decreased energetic capacity [2;5]. Several studies have shown that specific
mtDNA polymorphisms and haplotypes are associated with increased risk for diseases
believed to have an environmental component. Since these studies have been epidemiologic
the distinct and interactive contributions of the mtDNA and nuclear backgrounds on the
molecular mechanisms of bioenergetic function in human populations has remained
uncertain [6–10]. One of the central ideas from this body of work is that mtDNA
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polymorphisms code for respiratory chains with different bioenergetic characteristics and
generation of reactive oxygen species.
To test this hypothesis we developed Mitochondrial – Nuclear eXchange (MNX) mice in
which nuclear and mitochondrial genomes have been exchanged from different M. musculus
strains. This approach is distinct from conplastic [11] and xenomitochondrial [12] animals in
that MNX mice are generated directly with 100% of the desired nuclear and mtDNA
complements from respective donor strains through nuclear transfer and thus do not require
repeated back-crossings (as do conplastics) to generate animals having the desired genotype.
Furthermore, MNX mice allow direct, unambiguous assessment of mtDNA contributions to
disease since there is no complexity introduced by potential nuclear cross-over and
combinational effects in the filial generations associated with standard backcrossing
methods used to generate conplastic mice. By using C57BL/6 and C3H/HeN mice which
have been previously shown to have distinct susceptibilities to dietary induced
atherosclerosis and insulin resistance [13–18], we generated MNX mice having either the
nucleus of a C57BL/6 or C3H/HeN mouse and the mtDNA of either the C3H/HeN or
C57BL/6 animal, respectively. Mitochondrial bioenergetics, cellular oxidant production, and
susceptibility to a model of cardiac volume overload of aortocaval fistula (ACF), a model
which recapitulates the problem of valvular regurgitation [19] associated with increased
oxidative stress [20;21] were examined in these mice compared to control animals (wildtype C57BL/6 and C3H/HeN). We show that mtDNA genetic background significantly
modulated bioenergetics, oxygen utilization, and oxidant production in cardiac tissue. In
addition, mtDNA background was a major determinant of ACF induced mitochondrial
damage in the left ventricle independent of nuclear background – the typically sensitive
C57BL/6 mouse was rescued from ACF induced mitochondrial damage by replacing the
C57BL/6 mtDNA with the C3H/HeN mitochondrial genome, whereas the previously ACF
resistant C3H/HeN mouse became sensitive when the C3H/HeN mtDNA was replaced with
the C57BL/6 mtDNA in the MNX mouse. These findings provide direct evidence and
support the concept that mitochondrial genetic background significantly influences cellular
bioenergetics and disease susceptibility.

Experimental Procedures
Generation of Mitochondrial – Nuclear eXchange (MNX) Mice
C57BL/6J and C3H/HeN mice were purchased from Jackson Laboratories (Bar Harbor, ME)
and Harlan Laboratories (Indianapolis, IN), respectively. Female donor mice (3–4 weeks of
age) were super-ovulated hormonally and paired with males of the same nuclear genotype.
Their cumulus masses were harvested as previously described to produce single-celled
embryos [22]. Pronuclear embryos were placed in M2 medium containing cytochalasin B (5
µg/mL) and colcemid (0.1µg/mL) at 37°C for five minutes, and remained in a microinjection
drop of the same medium at room temperature to prevent lysis during manipulation. A
micropipette similar in size and shape to a beveled pipet used for embryonic stem cell
injection injections was used to remove both pronuclei of each embryo. First, the pipet was
positioned so that it put slight pressure on the zona pellucida. Then a high-intensity piezo
pulse was applied until the zona was ruptured. The pipet was slowly advanced to each
pronucleus, and with gentle suction applied to the needle, the two pronuclei were aspirated
and removed as a single unit (karyoplast). The isolated pronuclei from one strain were then
implanted into the enucleated embryo of the other strain. Ten centimeter tissue culture
dishes were loaded with microdrops of M2 medium and covered in mineral oil and each
embryo was placed into its own drop of media. An electrode was placed into the drop
positioning the embryo between the two poles. A single 90 V pulse was applied to each reconstructed zygote and all zygotes were cultured overnight [22]. Two-cell embryos were
transferred to the ostia of oviducts of 0.5 day CD-1 pseudopregnant mice to term. Nuclear
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genotype and mtDNA haplotype were verified in offspring via nuclear SNP and complete
mtDNA genome sequence analysis.
MNX mouse colonies were generated by crossing female MNX mice (mtDNA haplotype
confirmed by sequencing) with males of the matching nuclear background. MtDNA
haplotypes were confirmed in F1 progeny by sequencing and subsequent generations by
restriction fragment length polymorphism (RFLP) analysis of PCR products screening for
diagnostic mtDNA SNP’s that delineate between the C57 and C3H mtDNAs (Supplemental
Figure S1). C57BL/6 and C3H/HeN mtDNA were distinguished based on an A to G
mutation at bp9348 that results in the loss of an AspI site in the C3H mtDNA but not the
C57 mtDNA. Animals used in these studies were F7 or higher generation.
Euthanasia
Mice were paralyzed by interperitoneal injection of Ketastat/Xylazine (60mg/kg Ketastat/
10mg/kg Xylazine) as previously described [23].
Cell-free Mitochondrial Preparations
Mitochondria were isolated following a modification of the method of Rasmussen et al.
using a custom-built mitochondria isolation station/homogenizer (CL Krumdieck, DR
Moellering) as previously described [24].
High Resolution Respirometry
Mitochondrial respiration assays using freshly isolated heart mitochondria (100 µg) were
performed by measuring oxygen consumption in a two-channel respirometer (Oroboros
Oxygraph with DatLab software; Oroboros, Innsbruck, Austria) as previously described
[25]. Respiration rates were measured with 15 mM glutamate/2 mM malate as a substrate
followed by addition of inhibitors. Determination of state 2, 3, and induced state 4
respiration rates were made in the presence of excess substrate alone (state 2), after the
addition of 100 µM ADP (state 3), and after addition of 2 µg/ml oligomycin (induced state
4), an inhibitor of the ATP synthase. Respiration through complex IV only was performed in
the presence of ascorbate and tetramethylphenylenediamine (TMPD) as previously
described [26].
ATP Quantification
Steady – state ATP levels were quantified in isolated cardiac mitochondria (100 µg) under
state 3 respiration using a luciferase based kit (Molecular Probes, Eugene, OR) following
manufacturer’s instructions. Briefly, ATP levels were determined in isolated mitochondria
(heart) after a 1 minute incubation in the absence or presence of glutamate/malate and ADP,
followed by addition of oligomycin. Negative controls including (i) mitochondria in the
presence of oligomycin prior to substrate and ADP addition, (ii) mitochondria with
glutamate/malate only, (iii) and ADP only (no mitochondria) were used. ATP levels
produced by mitochondria following ADP addition were calculated using standard curves of
known ATP concentrations.
NADH dehydrogenase, Succinate dehydrogenase, and Cytochrome c Oxidase Activities
Enzymatic activites for complexes I, II and IV were measured as previously described [27].
Isolated heart mitochondria were used for all assays. For complex I, rotenone was added as
negative control and also subsequently to account for any rotenone insensitive activity. The
complex II assay measured the reduction of 2,6-cichlorophenolindophenol (DCPIP) coupled
to complex II catalyzed reduction of decylubiquinone. Complex IV activity was measured
by following the oxidation of reduced cytochrome c.
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Blue Native Proteomics
Composition and quantification of mitochondrial electron transport chain proteins were
determined in isolated cardiac mitochondria as previously described [28].
Cardiomyocyte Isolation
Primary adult cardiac myocytes were isolated from sham and ACF mice from each of the
different strains, as described previously [29]. Briefly, hearts were perfused with perfusion
buffer (120 mM NaCl, 15 mM KCl, 0.5 mM KH2PO45 M NaHCO310 mM HEPES, and 5
mM glucose, pH 7.0) for 5 min and digested with perfusion buffer containing 2%
collagenase II (Invitrogen, Carlsbad, CA) for 30 min at 37°C. The right ventricle, atria and
apex were removed before the perfused-heart was minced. The digestion was filtered and
washed, and the cells were pelleted. Only samples with purity > 95% and viability (rodshaped) > 80% were used.
Cellular Bioenergetics
To determine the effects of mitochondrial haplotype on cellular bioenergetics, an XF24
analyzer (Seahorse Bioscience, Billerica, MA) was used to measure O2 consumption by live
cells in culture [30]. This instrument allows for high throughput, real-time, non-invasive
measurements of O2 consumption by using fluorescent probes adhered to disposable assay
cartridges. These measurements can then be used to correlate O2 consumption rate (OCR) to
mitochondrial function. Primary adult cardiac myocytes were attached to specialized V28
plates (Seahorse Bioscience, Billerica, MA) coated with laminin at 7,500 cells/well. The
cells were then allowed to attach for 2 hr, after which time the culture media was changed to
MEM supplemented with 1% FBS (Atlanta Biologicals, Lawrenceville, GA) and 4 mM Lglutamine (Invitrogen) for the XF24 assays.
Various parameters of mitochondrial function were measured utilizing the ability of the
XF24 to inject compounds into the wells through an assay as described previously [30].
Briefly, basal O2 consumption of the primary adult cardiac myocytes was determined by
measuring the OCR of the cells over time without any treatment. Next, FCCP (1 µM) was
injected to stimulate the maximal OCR of the cells. This maximal OCR also allows for the
calculation of the reserve capacity, which is the difference between the maximal and basal
OCR, and represents the cells spare mitochondrial function that is available to be utilized
during an increased work load or stress. Finally, antimycin A (10 µM) and rotenone (1 µM)
were injected simultaneously to completely inhibit the mitochondrial electron transport
chain, thus yielding the non-mitochondrial OCR of the myocytes.
Mitochondrial membrane potential (Δψ) and ROS generation in cardiomyocytes
The mitochondrial inner membrane electrochemical Δψ was assessed using epifluorescence
microscopy with 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide
(JC-1). Briefly, adult cardiomyocytes were seeded in a four-well chambered coverglass.
Live cells were then incubated in culture medium supplemented with JC-1 (5 µM) for 30
min or DCF-DA (20 µM) for 20 min at 37°C. Next, cells were washed with serum complete
medium, and images were acquired from three or more randomly chosen fields using an
inverted epifluorescence microscope with suitable filter setup (model IX70; Olympus). The
levels of JC-1 (red and green) and DCFH-DA (green for ROS generation) fluorescence were
measured. The authors appreciate the considerations related to the use of DCFH-DA for the
detection of ROS [31], and under the current circumstances (changing only the mtDNA), we
believe its use to be reasonable. Quantitative data were expressed as total red channel pixel
intensity per number of cell. Results are mean ± SEM from 35–50 cardiomyocytes.
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Aortocaval Fistula Surgery
Control (C57n:C57mt and C3Hn:C3Hmt) and MNX (C57n:C3Hmt and C3Hn:C57mt) male
mice (18–24 weeks) were used for volume overload studies. An aortocaval fistula (ACF)
was surgically created as described previously [20]. Briefly, ACF and sham operations were
performed under sterile conditions on all four strains of mice at 18 to 24 wk of age. With
mice under isoflurane anesthesia, the abdominal cavity was opened via a midline incision,
and a fistula was created between the abdominal aorta and the inferior vena cava. Induced
sham and ACF mice were sacrificed 3 days after surgery, at which point the hearts were
excised and used for the isolation of cardiomyocytes for bioenergetic measurements, or for
LV sections for transmission electron microscopy. All groups had a decrease in mean
arterial pressure (MAP) indicating successful ACF.
Transmission Electron Microscopy
Heart LV tissue was fixed in Karnovsky’s solution (2% paraformaldehyde/2/5%
glutaraldehyde in 0.1 M phosphate buffer), and treated as previously described for TEM
[21]. For analysis, n = 2 animals were used for the controls (C57n:C57mt and C3Hn:C3Hmt)
and C57n:C3Hmt MNX, per group (sham and ACF); for the C3Hn:C57mt MNX animals 3
ACF and 4 shams were used. A minimum of 8 different fields were analyzed per mouse. For
the calculation of average mitochondrial number per field, samples were blinded; a total of
78 fields were analyzed with a minimum of 8 fields per group.
Statistical Analyses
Results are expressed as means ± SE. ANOVA was used to test the null hypothesis that all
samples were drawn from a single population and if the significant differences existed (P <
0.05), a Student-Newman-Keuls test was used for group comparisons. All analyses were
carried out using SigmaStat statistical software.

Results
Generation of Mitochondrial – Nuclear eXchange (MNX) mice
C57BL/6 and C3H/HeN mouse strains were used to produce Mitochondrial – Nuclear
eXchange (MNX) mice because these strains show significant differences in their
susceptibility to dietary induced atherosclerosis, insulin resistance and obesity, and have
distinct mtDNA sequences [13–18;32]. MNX mice were generated by enucleating fertilized
oocytes from one strain and reconstituting with the nucleus from the other (Supplemental
Figure S1). MNX embryos were then implanted into a surrogate mother and resulting
offspring had the nuclear genome of one strain and the mitochondrial genome of the other;
MNX nomenclature is indicated by strainnuclear:strainmtDNA (strainn:strainmt), e.g. mice with
C3H nuclear DNA and C57 mtDNA are indicated by C3Hn:C57mt (Supplemental Figure
S1). Genetic identity was initially confirmed via SNP analysis of a panel of 38
distinguishing nuclear SNPs (Supplemental Table S1) and mtDNA sequence analysis of F0
founders and F1 offspring reveal that C57 and C3H mouse mitochondrial haplotypes distinct
at three locations in terms of missense and tRNA mutations, consistent with previous reports
[32]. MtDNA haplogroup was determined in subsequent generations of MNX mice from tail
clips (at weaning) and heart tissue (subsequent to sacrifice) by restriction fragment length
polymorphism analysis using the restriction enzyme AspI which cleaves a 385 base pair (bp)
PCR product into 274 bp + 111 bp product for the C57 mtDNA whereas the C3H mtDNA
remains uncut (Supplemental Figure S1). Similarly, BclI cleaves a 204 bp PCR product into
166 + 38 bp products for the C3H mtDNA while the C57 mtDNA is not cleaved
(Supplemental Figure S1). All MNX mice were healthy and fertile with no overt physical or
behavioral phenotypes.
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Mitochondrial Bioenergetic Assessment
Cardiac mitochondrial oxygen consumption experiments were performed with control and
MNX mice. No differences were observed in the presence of the complex I substrates
glutamate and malate alone (state 2 respiration). State 3 respiration rates were significantly
different (P < 0.05) between mitochondria isolated from control C57 and C3H mice and
moreover, these rates were significantly changed by mtDNA background, as shown in the
MNX animals (Figure 1A). No significant differences were observed between groups in the
presence of oligomycin, an inhibitor of the ATP synthase (Figure 1A). Consequently, under
conditions of ATP generation (State 3 respiration), the mtDNA significantly influenced
mitochondrial oxygen consumption. Next, ATP generation was measured in heart
mitochondrial isolates under state 3 conditions. Figure 1B shows that mitochondria
harboring the C57 mtDNA generated more ATP compared to those having the C3H
mtDNA, irrespective of the nuclear background. These data suggest that the relative
proportion of oxygen utilized for generating ATP (State 3) versus non-ATP oxygen
consumption (oligomycin resistant) in the mitochondrion was dominated by mitochondrial
genetic background. This is illustrated in Figure 1C which shows that mitochondria with the
C57 mtDNA (C57n:C57mt and C3Hn:C57mt) utilize a significantly (P < 0.05) lower
proportion of oxygen for ATP production compared to those with C3H mtDNA
(C3Hn:C3Hmt and C57n:C3Hmt).
To determine the impact of mtDNA background on mitochondrial membrane potential and
cellular ROS production, JC-1 and DCF-DA fluorescence was measured in isolated
cardiomyocytes (Figures 2 and 3). Cardiomyocytes sharing the same mtDNA background
had more similar measures of both mitochondrial membrane potential (Figure 2A and B)
and cellular ROS production (Figure 3A and B), independent of nuclear background; cells
harboring the C3H mtDNA (C3Hn:C3Hmt and C57n:C3Hmt) had the lowest membrane
potentials and cellular ROS levels compared to those sharing the C57 mtDNA (C57n:C57mt
and C3Hn:C57mt) which had significantly (P < 0.05) higher membrane potentials and
cellular ROS (Figures 2 and 3). These findings strongly suggest that mtDNA background
significantly influences cellular bioenergetics and ROS formation.
NADH dehydrogenase and Cytochrome c oxidase (CO) mtDNA missense mutations
MtDNA sequence results revealed that C57 and C3H mouse mitochondrial haplotypes had
two distinct missense mutations, an A to C transversion at nucleotide 9461 in subunit III of
NADH dehydrogenase (ND3), and a G to A transition at nucleotide 9348 in subunit III of
cytochrome c oxidase (CO3), consistent with previous reports [32]. The ND3 mutation
results in the replacement of a methionine start codon in the C57 with an isoleucine codon in
the C3H which could potentially influence ND3 levels in complex I. However proteomic
analysis revealed no differences in detectable complex I subunit levels between mouse
strains, and no differences in complex I enzyme activity were observed between
mitochondrial isolates of C57 and C3H hearts (Supplementary Figure S2). Similarly, activity
of complex II (succinate dehydrogenase) which contains no mtDNA encoded subunits,
showed no differences between mouse strains (Supplementary Figure S3). In contrast, the G
to A mutation in CO3 replaces a highly conserved valine to isoleucine at AA248 in subunit
III between the C57 and C3H mouse, respectively (Figure 4A and B). While this change
does not appear to affect either CO subunit II levels (Figure 4C) nor the levels of the CO
holoenzyme (Figure 4D and E), quantification of CO activity in heart mitochondria by
following the oxidation of reduced cytochrome c revealed those with the C57 mtDNA had a
slightly higher activity than those having the C3H mtDNA, suggesting that CO activity
segregated with mtDNA background (Figure 4F). Complementary analysis of complex IV
respiration using ascorbate + TMPD showed that respiration rates between C57n:C57mt and
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C57n:C3Hmt mitochondrial isolates were significantly different. But the activity of the
C3Hn:C3Hmt and C3Hn:C57mt mice was not statistically different (Figure 4G).
MtDNA background affects susceptibility to cardiac volume overload (VO)
To determine whether these changes associated with mitochondrial genetic background and
bioenergetics also influenced susceptibility to cardiac stress, a heart volume overload (VO)
model was performed using the aortocaval fistula (ACF) mouse model [19]. Control
(C57n:C57mt and C3Hn:C3Hmt) and MNX (C57n:C3Hmt and C3Hn:C57mt) mice underwent
sham surgery or 3 days of ACF and heart left ventricle (LV) tissue was excised and
examined using transmission electron microscopy (TEM). Figure 5 shows dramatic
ultrastructural changes in the LV from ACF treated C57 control mice (C57n:C57mt),
indicating substantial myofibrillar and mitochondrial degeneration, whereas C3H control
mice (C3Hn:C3Hmt) showed very little disruption of the cytoskeleton and myofibrils, only a
minor degree of mitochondrial swelling and thus are minimally impacted by 3 days of ACF.
Remarkably, susceptibility to ultrastructural changes was inherently linked to the
mitochondrial genetic origin and not the nuclear background; C57n:C3Hmt mouse hearts had
little or no evidence of the pathological structural changes observed in the C57n:C57mt
animals in response to ACF (Figure 5), whereas the C3Hn:C57mt had marked pathological
changes compared to C3Hn:C3Hmt mice in response to ACF treatment.
Finally, to assess the ACF effects on cardiomyocyte bioenergetics, oxygen consumption
rates (OCRs) were determined in isolated cardiomyocytes from both sham and ACF treated
mice (Figure 6). ACF treatment significantly decreased the maximal OCR in
cardiomyocytes compared to cells derived from sham treated animals which harbored the
C57 mtDNA (C57n:C57mt and C3Hn:C57mt), independent of nuclear background, whereas
no differences were seen in those sharing the C3H mtDNA (C3Hn:C3Hmt and C57n:C3Hmt).
Interestingly, the maximal OCR in the sham treated animals was lowest in those having the
C3H mtDNA (271 + 43.4 and 336 + 52.8 pmol O2/min/µg protein, in C3Hn:C3Hmt and
C57n:C3Hmt mice respectively), versus those harboring the C57 mtDNA (452 + 53.3 and
444 + 92.4 pmol O2/min/µg protein in C57n:C57mt and C3Hn:C57mt mice, respectively)
consistent with the findings that complex IV activity was decreased in mitochondria having
the C3H mtDNA. Interestingly, it was also observed that the basal respiration rate was
higher in the C57n:C57mt sham animals compared to the other groups; to determine a
potential basis for this difference mitochondrial numbers per cell were estimated by
calculating the mean number of mitochondria observed per TEM field in the sham animals.
Figure 7 reveals that the C57n:C57mt mice had significantly higher numbers of mitochondria
compared to all remaining groups, which had similar amounts of mitochondria, potentially
providing an explanation for the observed differences in basal rates. No differences in
mitochondrial number were observed between ACF versus sham animals within each strain
(data not shown).

Discussion
The factors that contribute to cellular bioenergetics and disease susceptibility are clearly
complex. The mitochondrion is a multifunctional organelle which plays a vital role in
energy production, cell growth, apoptosis, thermogenesis and redox signaling.
Mitochondrial genetics has an “aging” mechanism in that there are thousands of copies of
mtDNA per cell compared to two nuclear alleles per cell; this redundancy allows for the
accumulation of mtDNA mutations and damage over time that contributes to an eventual
decline in mitochondrial function with age [2;33–35]. Additionally, studies have shown that
disease risk factors such as hypercholesterolemia and cigarette smoking increase
mitochondrial damage and alter function in cardiovascular tissues [23;35–37]. Most ancient
nuclear DNA polymorphisms are common to all global populations [38] whereas by virtue
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of its maternal transmission, the mtDNA displays marked regional variation. Maternal
family history of certain diseases has also been suggested to convey greater risk than
paternal history [39;40] and although it is thought that this association may be due to
offspring – maternal behaviors, and/or nutritional effects that were experienced in utero
[41], additional studies have shown that in utero exposure to disease risk factors increase
mtDNA damage [37;42].
Wallace and co-workers originally proposed the mitochondrial paradigm in which
environmental factors influenced prehistoric human radiation patterns and survival by
selecting for aspects of mitochondrial function [2;4]. As humans radiated out of Africa, they
encountered colder climates, a higher dependence upon dietary animal proteins and fats, and
accumulated a greater frequency of mtDNA missense mutations [2;4]. It has been suggested
that these mutations altered mitochondrial economy (the conversion of caloric energy into
ATP, heat, and oxidants) enabling individuals harboring these mtDNAs to more effectively
utilize caloric energy to meet local environmental challenges and establish populations
northward from Africa. These findings have led to the hypothesis that in the present era,
with the development of a more sedentary lifestyle, excessive caloric intake, and climate
control, these variants in mitochondrial function influence cellular ROS formation and
therefore disease susceptibility. Differences in the mtDNA have been linked to behavioral,
cognitive, and age – related deafness in conplastic mice [11;43–45], these studies did not
report mitochondrial or cellular bioenergetics. Other investigators using conplastic or cybrid
approaches have examined the effects of mtDNA variation upon bioenergetics and ROS
production [46–49]; and have concluded that ROS production can be influenced by mtDNA
sequence, and that respiratory capacity, “per molecule of mtDNA” could be affected by
mtDNA sequence [46]. Interpretation of these studies is complicated bv the possibility that
Mendelian allelic selection events for “fitness” are also influenced by mtDNA – nuclear
interactions. In this scenario selection for specific nuclear alleles may occur during the
sequential backcrossings of hybrid conplastic animals resulting in a model with a unique
combination of mitochondrial and nuclear backgrounds which cannot be controlled by the
parent strains. MNX mice overcome this problem because they are produced directly
without the generation of nuclear hybrids (thus circumventing any potential issue of nuclear
allelic selection in hybrid animals), generating an animal having desired nuclear and
mitochondrial genome in a single step. Consequently, MNX mice provide a means of
unequivocally testing the influence of mtDNA background on cell function by
circumventing a potential confounder of nuclear allelic selection that can occur with the
generation of nuclear hybrids using conplastic methods.
In this regard, we now provide direct evidence that mtDNA plays a significant role in
controlling the relationship between mitochondrial energetic and ROS formation, and this is
associated with susceptibility to ACF induced pathological changes in the heart, a model of
volume overload which ultimately leads to heart failure. While missense mutations exist
between the C3H/HeN and C57BL/6 mtDNAs at both complex I (NADH dehydrogenase
subunit 3) and complex IV (cytochrome c oxidase subunit III, COIII), no significant
differences were observed in complex I protein or activity levels, whereas differences were
noted at complex IV. While both spectrophotometic and polarographic assays for complex
IV activity showed significant changes in mice harboring the C57 versus C3H mtDNA
background, the spectrophotometic assay also showed significant differences between both
controls and nuclear-matched MNX, whereas the polarographic measures showed only
differences between the C57n:C57mt versus C57n:C3Hmt animals but not the C3Hn:C3Hmt
versus C3Hn:C57mt mice. Because these assays utilize different mechanisms to quantify
cytochrome c oxidase activity, e.g. by monitoring the rate of oxidation of exogenously
available reduced cytochrome c (a single electron donor) via absorbance changes versus the
reduction of oxygen (a four electron acceptor) dependent upon endogenous cytochrome c
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levels, using an oxygen electrode, these differences in sensitivity and mechanism probably
underlie the discrepancy between the activity assays for complex IV. The COIII mutation
replaces a highly conserved valine to an isoleucine. CO subunits I and II act as the catalytic
subunits for redox reactions and proton pumping for cytochrome c oxidase, whereas subunit
III is thought to play a role in the structural relationship between subunits I and II. It has also
been shown that COIII plays a key role in proton pumping - absence of this subunit
decreases proton pumping significantly by changing the pKa of Asp132 of subunit I [50].
Thus, the valine to isoleucine change in COIII may alter its conformation and in turn
influence cytochrome c oxidase enzymatic activity and its ability to pump protons across the
membrane, potentially manifesting as altered mitochondrial economy. This is consistent
with the observation that under conditions of coupling, mitochondria with the C57BL/6
mtDNA have higher membrane potentials, consume less oxygen, and generate more ATP
compared to those harboring the C3H/HeN mtDNA (Figures 1 and 2). While seeming
contradictory with the higher CO enzyme activity results observed in with the C57BL/6
mtDNA (Figure 4), these measures were performed in absence of a membrane potential
using uncoupled mitochondria. The higher membrane potential and economy associated
with the C57BL/6 mtDNA under coupled conditions likely regulates mitochondrial oxygen
consumption. Another feature not yet understood is whether the differences observed
between the isolated mitochondrial experiments and cardiomyocyte respiration studies are
due to: 1) the fact that cellular bioenergetics substrates are provided by the metabolic
activity of the cells versus the saturating substrate conditions used for the isolated
mitochondria experiments; 2) differences in mitochondrial number in hearts as shown in
Figure 7; 3) both 1 and 2, or 4) as yet unidentified mechanisms. Regardless, the combination
of mitochondrial and nuclear genetic background also may influence organelle biogenesis
and regulation of mitochondrial number per cell. Future studies to further explore these
observations are underway.
Several studies have noted differences in cardiovascular disease (CVD) susceptibility
between certain strains of mice having specific nuclear gene differences [11;17;18;51–55].
For example, it has been suggested that the C3H/HeJ mouse (a descendant substrain of the
C3H/HeN mouse used herein) is resistant to atherosclerosis by virtue of being Toll receptor4 (TLR4) null [56]. However, many TLR4 competent mice are also atherosclerosis resistant,
such as the C3H/HeN and the A/J mouse, among others. While the loss of TLR4 may
contribute to athero-resistance, it is not the only potential basis. Differences in nicotinamide
nucleotide transhydrogenase (NNT) gene expression, a protein that regenerates NADPH
within the mitochondrial inner membrane, have been suggested as the basis for the observed
increase in dietary induced insulin resistance and obesity in C57 mice [17;52;53]. However,
it remains unclear whether decreased or increased expression of NNT conveys these effects
since studies suggesting both outcomes have been reported [52;55;57;58]. It is well
established that other strains of mice which are NNT competent also display dietary induced
insulin resistance and obesity [55;58] and hence differences at this locus cannot be the sole
explanation for susceptibility. The findings that C57 mice are also more prone to obesity,
insulin resistance, dietary induced atherogenesis, and are generally more vulnerable to the
effects of environmental oxidants [17;53;56;58] compared to C3H mice are consistent with
the notion of differences in mitochondrial function. These same traits would be predicted if
differences in mitochondrial economy that influenced caloric utilization and oxidant
generation existed between mouse strains.
Why some individuals with identical CVD risk factor profiles develop disease while others
do not is unclear. In addition to endogenous and environmental risk factors (i.e.
hypercholesterolemia and tobacco smoke exposure, respectively), CVD susceptibility is
increased by age, family history [39;40], and ethnicity [59]. The “common disease, common
variants” hypothesis suggests that CVD susceptibility has a multi-factorial, polygenic basis
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in that genetic variants present in many normal individuals, each with a relatively small
effect, alone or in combination with modifier genes and environmental factors, contribute to
overall CVD risk [60]. Numerous studies have sought associations between polymorphic
gene mutations and CVD development. However, many original associations were lost in
larger scale studies or were not as predictive for risk as plasma markers such as cholesterol
levels [61–64]. Consequently, while important in advancing our understanding of gene
groups that may be involved in influencing predilection to disease development, the
underlying genetic and physiologic basis of why these differences exist are not well
understood. A complementary possibility is that differences in mitochondrial function which
are influenced by mtDNA affect cytoplasmic signaling to the nucleus thereby influencing
aspects of nuclear gene expression. While similar to concepts of retrograde signaling, subtle
changes in mitochondrial quality would play a role in the regulation of nuclear gene
expression and hence, be distinct from current concepts of retrograde signaling that usually
invoke significant mitochondrial stress or loss of function [65]. In this manner, changes in
mitochondrial function, influenced by mtDNA mutations, would potentially have significant
impact upon the expression of nuclear genes involved in disease susceptibility. In addition, it
is likely that any change in mitochondrial function associated with mtDNA mutation would
have distinct effects on different tissues. It is well established that a hierarchy exists in terms
of tissue sensitivity to pathogenic mtDNA mutations [2;66], hence it is likely the same
occurs with “normal” polymorphisms. Because the focus of this study was upon the heart
the impact of different mtDNA backgrounds on other tissues or organs was not explored;
however based upon what is known regarding pathogenic mtDNA mutations, it is possible
that the same mtDNA background will have varied effects upon different tissues. It is also
plausible that this interaction would be significantly affected by environmental factors and
the combination of mtDNA and nuclear genomes. Consequently, we view the mitochondrial
paradigm for common disease development as a significant yet complementary component
of the “common disease, common variants” explanation for disease susceptibility. Future
studies investigating this potential aspect of mitochondrial genetics in cellular bioenergetics
and disease development and progression are now possible using MNX mice.
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Figure 1. Mitochondrial function and utilization segregates with mitochondrial haplotype

Respiration and ATP levels were determined in mitochondria isolated from control
(C57n:C57mt and C3Hn:C3Hmt) and MNX (C57n:C3Hmt and C3Hn:C57mt) mice (N ≥ 5 per
group). For the bar graphs, the nuclear genome for each group is indicated on the X-axis,
whereas the filled or open bars indicate the presence of either the C57 mtDNA or C3H
mtDNA, respectively. (A) Respiration under state 2 (glutamate/malate), state 3 (glutamate/
malate + ADP), and induced state 4 (glutamate/malate + ADP, followed by oligomycin
addition). An asterisk (*) indicates a significant difference (p < 0.05) exists compared to
nuclear genome matched control. (B) ATP levels determined under state 3 respiration
conditions. An asterisk (*) indicates a significant difference (p < 0.05) exists compared to
nuclear genome matched control. (C) Pie charts illustrating oxygen utilization profiles
(percent oxygen consumption for ATP or non-ATP purposes) for controls (C57n:C57mt and
C3Hn:C3Hmt) and MNX (C57n:C3Hmt and C3Hn:C57mt) mice determined in heart
mitochondrial isolates. Percent oxygen utilization for ATP production was determined by:
ATP = (State 3 – Oligomycin)/State 3, whereas the proportion of oxygen utilized for nonATP purposes was calculated by non-ATP = Oligomycin/State 3. The pie charts show that
overall oxygen utilization was significantly influenced by the mtDNA (P = 0.04).
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Figure 2. Mitochondrial membrane potential is influenced by the mtDNA in cardiomyocytes

A. Mitochondrial membrane potential was determined using the JC-1 fluorescence method
(representative images); cardiomyocytes isolated from control (C57n:C57mt and
C3Hn:C3Hmt) and MNX (C57n:C3Hmt and C3Hn:C57mt) mouse hearts (emission-green 529
nm/emission-red 590 nm) B) Bar graph illustrating the quantification of fluorescence
relative to the C57n:C57mt controls. The nuclear genome for each group is indicated on the
X-axis, whereas the filled or open bars indicate the presence of either the C57 mtDNA or
C3H mtDNA, respectively. Data = mean ± SEM from 35–50 cardiomyocytes. An asterisk
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(*) indicates a significant difference (p < 0.001) exists compared to nuclear genome matched
control.
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Figure 3. Cellular ROS generation is influenced by the mtDNA in cardiomyocytes

A) Cardiomyocytes isolated from control (C57n:C57mt and C3Hn:C3Hmt) and MNX
(C57n:C3Hmt and C3Hn:C57mt) mouse hearts were treated with DCF-DA and cellular
fluorescence measured (485 nm/530 nm - excitation/emission) B) Bar graph illustrating
fluorescence relative to the C57n:C57mt controls. The nuclear genome for each group is
indicated on the X-axis, whereas the filled or open bars indicate the presence of either the
C57 mtDNA or C3H mtDNA, respectively. Data = mean ± SEM from 35–50
cardiomyocytes. An asterisk (*) indicates a significant difference (p < 0.001) exists
compared to nuclear genome matched control.
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Figure 4. Complex IV (cytochrome oxidase) protein levels and activity in C57 and C3H
mitochondria

Proteomic and enzymatic analyses of heart mitochondrial isolates for cytochrome c oxidase.
(A) MtDNA sequence of C3H and C57 mice showing a G to A transitional missense
mutation in subunit III of complex IV. (B) Conservation of valine at AA248 throughout
vertebrates. (C) Levels of cytochrome oxidase (COX) subunit II and (D) blue native 2D
proteomics of additional cytochrome oxidase subunits. (E) Quantification of subunits,
indicating no differences in the expression of isolated complex IV subunits. (F) Cytochrome
c oxidase activity following the oxidation of reduced cytochrome c at 550 nm in cardiac
mitochondria from control (C57n:C57mt and C3Hn:C3Hmt) and MNX (C57n:C3Hmt and
C3Hn:C57mt) mice. The nuclear genome for each group is indicated on the X-axis, whereas
the filled or open bars indicate the presence of either the C57 mtDNA or C3H mtDNA,
respectively. An asterisk indicates a significant difference (*p < 0.05) exists between the
nuclear matched control and MNX animal; the double asterisk (**) with lines indicates a
significant difference exists between groups having the C57 versus C3H mtDNA. (G)
Cytochrome c oxidase oxygen consumption was determined in cardiac mitochondria using
ascorbate + TMPD from control (C57n:C57mt and C3Hn:C3Hmt) and MNX (C57n:C3Hmt
and C3Hn:C57mt) mice. The nuclear genome for each group is indicated on the X-axis,
whereas the filled or open bars indicate the presence of either the C57 mtDNA or C3H
mtDNA, respectively. An asterisk indicates a significant difference (*p < 0.05) exists
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between the nuclear matched control and MNX animal; the double asterisk with lines
indicates a significant difference exists between groups having the C57 versus C3H mtDNA.
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Figure 5. Transmission Electron Microscopy (TEM) of left ventricular (LV) tissue in sham and
aortacaval fistula (ACF) treated mice

Representative images from control (C57n:C57mt and C3Hn:C3Hmt) and MNX
(C57n:C3Hmt, and C3Hn:C57mt) mice that underwent either sham or ACF surgery and
sacrificed 3 days thereafter, and LV tissue prepared for TEM. Mitochondrial swelling and
disorganization along with myofibrillar degeneration was observed in the ACF treated mice
having the C57 mtDNA (C57n:C57mt and C3Hn:C57mt animals), which was absent in the
ACF treated mice having the C3H mtDNA (C3Hn:C3Hmt and C57n:C3Hmt mice). Mag =
4500x (insets are 9000x, arrows indicate enlarged area). Imaging by Emlabs, Inc.,
Birmingham, AL.
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Figure 6. Cardiomyocyte bioenergetics in sham and aortacaval fistula (ACF) treated hearts

Graphs illustrating basal, maximum, and non-mitochondrial oxygen consumption rates in
cardiomyocytes isolated from sham and ACF treated hearts for (A) C57n:C57mt(B)
C3Hn:C3Hmt(C) C57n:C3Hmtand (D) C3Hn:C57mt (see methods, N > 5 per group).
Asterisks (*) indicate a significant (P < 0.05) difference exists between ACF and sham
treated control.
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Figure 7. Average number of mitochondria in left ventricular tissue in control and MNX mice

Graph illustrating mean number of mitochondria per TEM field from control (C57n:C57mt
and C3Hn:C3Hmt) and MNX (C57n:C3Hmtand C3Hn:C57mt) mice. Values were calculated
from a total of 78 fields with a minimum of 8 fields per mouse strain. Asterisks (*) indicate
a significant (P < 0.05) difference exists between C57n:C57mt versus
C3Hn:C3HmtC57n:C3Hmt and C3Hn:C57mt left ventricular tissue.

